No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali.
about
Gametocyte clearance dynamics following oral artesunate treatment of uncomplicated falciparum malaria in Malian childrenLack of artemisinin resistance in Plasmodium falciparum in northwest Benin after 10 years of use of artemisinin-based combination therapyClinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient dataPolymorphisms in K13 and Falcipain-2 Associated with Artemisinin Resistance Are Not Prevalent in Plasmodium falciparum Isolated from Ugandan ChildrenAntimalarial drug resistance in Africa: key lessons for the futureReduced susceptibility of Plasmodium falciparum to artesunate in southern MyanmarGenetically Determined Response to Artemisinin Treatment in Western Kenyan Plasmodium falciparum ParasitesPlasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia.Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic studyDelayed anemia assessment in patients treated with oral artemisinin derivatives for uncomplicated malaria: a pooled analysis of clinical trials data from Mali.Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.Plasmodium falciparum field isolates from areas of repeated emergence of drug resistant malaria show no evidence of hypermutator phenotype.Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malariaObserving in real time the evolution of artemisinin resistance in Plasmodium falciparumPolymorphisms in the K13-propeller gene in artemisinin-susceptible Plasmodium falciparum parasites from Bougoula-Hameau and Bandiagara, MaliExamining Plasmodium falciparum and P. vivax clearance subsequent to antimalarial drug treatment in the Myanmar-China border area based on quantitative real-time polymerase chain reactionIn Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine SensitivityPolymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapyIn Vivo Efficacy and Parasite Clearance of Artesunate + Sulfadoxine-Pyrimethamine Versus Artemether-Lumefantrine in Mali.Manual blood exchange transfusion does not significantly contribute to parasite clearance in artesunate-treated individuals with imported severe Plasmodium falciparum malariaK13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa.Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity.Ahead of the curve: next generation estimators of drug resistance in malaria infections.Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study.Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether-lumefantrine treatment in Mali.Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009Analysis of major genome loci underlying artemisinin resistance and pfmdr1 copy number in pre- and post-ACTs in western Kenya.Sustained High Cure Rate of Artemether-Lumefantrine against Uncomplicated Plasmodium falciparum Malaria after 8 Years of Its Wide-Scale Use in Bagamoyo District, Tanzania.Evaluation of the comparative efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine and artesunate-amodiaquine-chlorpheniramine (Artemoclo™) for the treatment of acute uncomplicated malaria in Nigerian children.No evidence of decreased artemisinin efficacy in a high-transmission malaria setting in Mali.malERA: An updated research agenda for insecticide and drug resistance in malaria elimination and eradication.Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children.Efficacy of artesunate-amodiaquine, dihydroartemisinin-piperaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger.Multiple Phenotypic and Genotypic Artemisinin Sensitivity Evaluation of Malian Plasmodium falciparum Isolates.School-aged children based seasonal malaria chemoprevention using artesunate-amodiaquine in Mali.Plasmodium falciparum Plasmepsin 2 Duplications, West AfricaHigh efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, TanzaniaEfficacy of Artemisinin-Based Combination Treatments of Uncomplicated Falciparum Malaria in Under-Five-Year-Old Nigerian Children Ten Years Following Adoption as First-Line AntimalarialsMalaria parasite clearance from patients following artemisinin-based combination therapy in Côte d'Ivoire
P2860
Q22773191-F9FABDAC-8C64-4B5E-A053-5126E0D7E761Q26209187-8671DB17-701F-4C6C-8537-E8B859CF13ACQ26783902-FC3DE63F-94D7-4920-9BE9-86F54C32D019Q27861962-C48B36B9-D047-4418-9AA2-C4C070E933D5Q28081457-3E56C115-CBB3-4D1A-944B-936456723800Q28487881-54588341-C83F-442A-BCB6-F333DB627F91Q28554000-21589F61-F911-440D-9076-FD3A0C2A7D4DQ30240158-A38CB790-1094-49DB-BC8D-D6FA47BA6B27Q30389796-48730578-F178-445B-A1D7-B9A12C63F8B1Q30850979-E85F3F7B-CA6B-42E1-834A-9C8BA8EA24A4Q30995133-02A50523-A0DC-43DA-91F2-7CCCE38534B1Q35047872-3837BB02-71FA-48F8-8CA6-08B22DFFD2E1Q35102694-56FBBDBE-203F-4065-967D-F39D69138984Q35608785-15ABF1C4-6EF0-4324-A3DD-00E0E5F783C5Q35616221-0B0C07F7-AA3C-4E81-98E7-40810CBA4444Q35991544-D9B9CD64-B69F-4F1A-9BB3-3F0B60CB5F5EQ36290734-1A61FD8C-5ED7-40CD-B8EF-6838F85C9B99Q36370090-20809CC7-5352-485C-9246-E12AB6AE10CAQ36644511-D8BCC98D-A965-495B-A425-4EC13EB261DFQ36741273-0A5E8915-7B72-4CC3-9E1B-FF123DA4E273Q36786733-A7E05463-B9A1-4450-B426-F43D00350500Q36796548-1A7E8A49-5259-4EB1-A534-D2AD08437CE4Q36961003-27763750-BAAC-4B08-B862-CDF687BB98B0Q37038288-E3B5D20D-D501-41DB-A7E8-C7FD64F75650Q37205700-55DDDEC1-12B8-4BD7-8A30-5AEE9B597544Q37621092-FDC478E8-B795-4B49-9E64-E13282689B2FQ37703517-E8408842-25E8-4FBC-A3F6-99E4922F847EQ39301470-E9577CF5-6C85-4F92-B5C4-AD0E31B486E9Q40075427-A97D1799-74B7-42A4-BEC4-7EAEA776E78DQ40210481-B83135AE-1374-46DE-A43C-22F3FCC8819AQ43216220-59D3999D-F543-41FD-9DF5-7892B1535806Q47130457-CF0CDB10-ED72-4C3F-8760-2A87CD448DE1Q47871895-04E89A03-04B3-4DE2-B6C5-70F09585B44BQ48023355-5DE8B2E3-97ED-494A-9D56-039E846C0A3CQ50048811-0629FF00-F98B-408B-9B97-4F2DD229406EQ55477044-818BDA90-8BA0-482C-A113-19B296AB7BB9Q56350341-BC3E1875-D556-4295-B189-E9063D0C315DQ56363463-D674B2A4-9783-423A-8EC7-F4DCB25C4E20Q56375478-7F9F28ED-4FCE-43FC-87B8-3CF34A8DA598Q59126227-10CE9259-EB9E-4CE8-A688-80119AEA8430
P2860
No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
No evidence of delayed parasit ...... ed falciparum malaria in Mali.
@ast
No evidence of delayed parasit ...... ed falciparum malaria in Mali.
@en
type
label
No evidence of delayed parasit ...... ed falciparum malaria in Mali.
@ast
No evidence of delayed parasit ...... ed falciparum malaria in Mali.
@en
prefLabel
No evidence of delayed parasit ...... ed falciparum malaria in Mali.
@ast
No evidence of delayed parasit ...... ed falciparum malaria in Mali.
@en
P2093
P2860
P50
P921
P1476
No evidence of delayed parasit ...... ed falciparum malaria in Mali.
@en
P2093
Amelia W Maiga
Bakary Sidibe
Kassim Sanogo
Oumar Bila Traore
Sekou Toure
P2860
P356
10.4269/AJTMH.2012.12-0058
P407
P50
P577
2012-07-01T00:00:00Z